Target validation and drug discovery using genomic and protein-protein interaction technologies

Area of Science:

• Biotechnology
• Pharmaceutical Sciences
• Genomics and Proteomics

Background:

• The human genome project's completion necessitates human proteome mapping for drug discovery.
• The pharmaceutical industry requires new drug targets to sustain growth and develop preclinical candidates.
• Identifying relevant protein targets is a significant challenge in drug development.

Purpose of the Study:

• To review technologies for identifying and validating drug targets within the human proteome.
• To highlight the importance of protein-protein interactions in target discovery.
• To address the challenge of selecting relevant targets from a vast proteomic dataset.

Main Methods:

• Utilizing genomic technologies for target identification.
• Employing protein-protein interaction mapping to understand biological pathways.
• Integrating proteomic data to discover and validate potential drug targets.

Main Results:

• Describes a paradigm for identifying drug targets using proteomic and genomic data.
• Emphasizes the critical role of protein-protein interaction networks in target validation.
• Provides a framework for selecting relevant 'needles' in the 'proteome haystack'.

Conclusions:

• Genomic and protein-protein interaction technologies are vital for identifying drug targets.
• Effective target identification is the crucial first step in the drug discovery pipeline.
• This approach supports the pharmaceutical industry's need for novel drug leads and sustained growth.